The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells
Open accessAbstract
Bacterial type II CRISPR-Cas9 systems have been widely adapted for RNA-guided genome editing and transcription regulation in eukaryotic cells, yet their in vivo target specificity is poorly understood. Here we mapped genome-wide binding sites of a catalytically inactive Cas9 (dCas9) from Streptococcus pyogenes loaded with single guide RNAs (sgRNAs) in mouse embryonic stem cells (mESCs). Each of the four sgRNAs we tested targets dCas9 to between tens and thousands of genomic sites, frequently characterized by a 5-nucleotide seed region in the sgRNA and an NGG protospacer adjacent motif (PAM). Chromatin inaccessibility decreases dCas9 binding to other sites with matching seed sequences; thus 70% of off-target sites are associated with genes. Targeted sequencing of 295 dCas9 binding sites in mESCs transfected with catalytically active Cas9 identified only one site mutated above background levels. We propose a two-state model for Cas9 binding and cleavage, in which a seed match triggers binding but extensive pairing with target DNA is required for cleavage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“| Delivery methods improvement | Application in cell culture [89–94] | Viral transduction | May cause accumulation of off-target mutations |”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [93]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“| Delivery methods improvement | Application in cell culture [89–94] | Plasmid transfection | May cause accumulation of off-target mutations |”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [93]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“| Delivery methods improvement | Application in cell culture [89–94] | RNP electroporation: Rapid transfection and turnover | Eliminate off-target effects |”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [93]
Experimental — accuracy not yet measuredIn the citing paper
“A key feature of our system is the transient expression of the nuclease Cas9, through delivery of mRNA. This allowed for sufficient exposure to the nuclease for gene repair and reduced concerns associated with long-term nuclease exposure34.”
From Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo (2016) · cites this paper as [34]
In the citing paper
“And moreover, DNA binding and cleavage by Cas9 are in some cases uncoupled, that is, Cas9 can bind to but not cleave DNA sequences that are partially complementary to sgRNA 49 and exert epigenomic regulatory effects, 43 44 which is unpredictable by silicon methods relying on base pairing.”
From CRISPR-Cas9: a new and promising player in gene therapy (2015) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Self-citationWebLogo: A Sequence Logo Generator: Figure 1Preprint
Crooks, G. E., Hon, G. C., Chandonia, J., & Brenner, S. E. (2004) · Genome Research · doi:10.1101/gr.849004 · Cited by 12,418
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Self-citationRepurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 944
Murugan, K., Suresh, S. K., Seetharam, A. S., Severin, A. J., & Sashital, D. G. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab163 · Cited by 25
Mak, J. K., Störtz, F., & Mináry, P. (2022) · BMC Genomics · doi:10.1186/s12864-022-09012-7 · Cited by 24
Synthetic genome readers target clustered binding sites across diverse chromatin states
Erwin, G. S., Grieshop, M. P., Bhimsaria, D., Do, T. J., Rodríguez‐Martínez, J. A., Mehta, C., Khanna, K., Swanson, S. A., Stewart, R. M., Thomson, J. A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604847113 · Cited by 24
In vivo gene therapy potentials of CRISPR-Cas9
Xue, H.-Y., Zhang, X., Wang, Y., Lu, X., Dai, W.-J., & Xu, Y. C. (2016) · Gene Therapy · doi:10.1038/gt.2016.25 · Cited by 24
Malik, A., Gul, A., Munir, F., Amir, R., Alipour, H., Babar, M. M., Bakhtiar, S. M., Paracha, R. Z., Khalid, Z., & Hayat, M. Q. (2021) · PeerJ · doi:10.7717/peerj.11409 · Cited by 23
Tips, Tricks, and Potential Pitfalls of CRISPR Genome Editing in Saccharomyces cerevisiae
Antony, J. S., Hinz, J. M., & Wyrick, J. J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.924914 · Cited by 24
The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases.
Peddle, C. F., & MacLaren, R. E. (2017) · PubMed · Cited by 23
Cenik, B. K., Aoi, Y., Iwanaszko, M., Howard, B. C., Morgan, M. A., Andersen, G. D., Bartom, E. T., & Shilatifard, A. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.11.007 · Cited by 22
CORALINA: a universal method for the generation of gRNA libraries for CRISPR-based screening
Köferle, A., Worf, K., Breunig, C., Baumann, V., Herrero, J., Wiesbeck, M. F., Hutter, L. H., Götz, M., Fuchs, C., Beck, S., et al. (2016) · BMC Genomics · doi:10.1186/s12864-016-3268-z · Cited by 20
Zhang, Z., Zeng, W., Zhang, W., Li, J., Kong, D., Zhang, L., Wang, R., Peng, F., Kong, Z., Ke, Y., et al. (2022) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiac431 · Cited by 22
Guide-specific loss of efficiency and off-target reduction with Cas9 variants
Zhang, L., He, W., Fu, R., Wang, S., Chen, Y., & Xu, H. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad702 · Cited by 27
Adapting CRISPR/Cas9 for Functional Genomics Screens
Malina, A., Katigbak, A., Cencic, R., Maïga, R. I., Robert, F., Miura, H., & Pelletier, J. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-801185-0.00010-6 · Cited by 22
Kim, J. H., Titus, K. R., Gong, W., Beagan, J. A., Cao, Z., & Phillips‐Cremins, J. E. (2018) · Methods · doi:10.1016/j.ymeth.2018.05.005 · Cited by 21
Yue, J.-J., Hong, C., Wei, P., Tsai, Y., & Lin, C. (2020) · Rice · doi:10.1186/s12284-019-0354-2 · Cited by 22
Determination of Cas9/dCas9 associated toxicity in microbesPreprint
Misra, C. S., Bindal, G., Sodani, M., Wadhawan, S., Kulkarni, S., Gautam, S., Mukhopadhyaya, R., & Rath, D. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/848135 · Cited by 22
Chromatin context-dependent effects of epigenetic drugs on CRISPR-Cas9 editing
Schep, R., Trauernicht, M., Vergara, X., Friskes, A., Morris, B., Gregoricchio, S., Manzo, S. G., Zwart, W. T., Beijersbergen, R. L., Medema, R. H., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae570 · Cited by 21
Single-Molecule Insight Into Target Recognition by CRISPR–Cas Complexes
Rutkauskas, M., Krivoy, A., Szczelkun, M. D., Rouillon, C., & Seidel, R. (2016) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2016.10.001 · Cited by 20
Targeted genome editing in Caenorhabditis elegans using CRISPR /Cas9
Farboud, B. (2017) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.287 · Cited by 20
Shaigani, P., Fuchs, T., Graban, P., Prem, S., Haack, M., Masri, M. A., Mehlmer, N., & Brueck, T. (2023) · Microbial Cell Factories · doi:10.1186/s12934-023-02033-1 · Cited by 23
The promise and peril of CRISPR gene drives
Zentner, G. E., & Wade, M. J. (2017) · BioEssays · doi:10.1002/bies.201700109 · Cited by 21
The prospects of CRISPR-based genome engineering in the treatment of neurodegenerative disorders
Shin, J. W., & Lee, J. (2017) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285617741837 · Cited by 21
Huang, L., Tian, H., Luo, J., Song, N., & Wu, J. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c00845 · Cited by 21
CRISPR Guide RNA Design Guidelines for Efficient Genome Editing
Schindele, P., Wolter, F., & Puchta, H. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0712-1_19 · Cited by 25
Baidukova, O., Oppermann, J., Kelterborn, S., Lahore, R. G. F., Schumacher, D., Evers, H., Kamrani, Y. Y., & Hegemann, P. (2022) · Nature Communications · doi:10.1038/s41467-022-35018-6 · Cited by 20
Chen, Y., Luo, X. L., Kang, R., Cui, K., Ou, J., Zhang, X., & Liang, P. (2023) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2023.07.007 · Cited by 23
Polycomb Responds to Low Levels of Transcription
Berrozpe, G., Bryant, G. O., Warpinski, K., Spagna, D., Narayan, S., Shah, S., & Ptashne, M. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.076 · Cited by 20
Applications of CRISPR systems in respiratory health: Entering a new ‘red pen’ era in genome editing
Moses, C., & Kaur, P. (2019) · Respirology · doi:10.1111/resp.13527 · Cited by 22
Identification of Guide-Intrinsic Determinants of Cas9 Specificity
Huston, N. C., Tycko, J., Tillotson, E. L., Wilson, C. J., Myer, V. E., Jayaram, H., & Steinberg, B. E. (2019) · The CRISPR Journal · doi:10.1089/crispr.2019.0009 · Cited by 20
Generation of Gene-Knockout Mongolian Gerbils via CRISPR/Cas9 System
Wang, Y., Zhao, P., Song, Z., Du, X., Huo, X., Lü, J., Liu, X., Lv, J., Li, C., Guo, M., et al. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00780 · Cited by 20
Advancements in genome editing tools for genetic studies and crop improvement
Ahmadikhah, A., Zarabizadeh, H., Nayeri, S., & Abbasi, M. S. (2025) · Frontiers in Plant Science · doi:10.3389/fpls.2024.1370675 · Cited by 21
Sapozhnikov, D. M., & Szyf, M. (2022) · Nature Protocols · doi:10.1038/s41596-022-00741-3 · Cited by 21
CRISPR-Cas9 recognition of enzymatically synthesized base-modified nucleic acids
Yang, H., Eremeeva, E., Abramov, M., Jacquemyn, M., Groaz, E., Daelemans, D., & Herdewijn, P. A. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac1147 · Cited by 19
Raper, A. T., Stephenson, A. A., & Suo, Z. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b05469 · Cited by 19
HLA DR Genome Editing with TALENs in Human iPSCs Produced Immune-Tolerant Dendritic Cells
Kwon, Y., Ahn, H.-S., Lee, J. W., Yang, H., Cho, H., Kim, S. J., Lee, S.-H., Yang, H.-M., Jang, H.-D., Kim, S. J., et al. (2021) · Stem Cells International · doi:10.1155/2021/8873383 · Cited by 19
CRISPR-Cas9 Genome Engineering: Trends in Medicine and Health
Zaib, S., Khan, I. A., & Saleem, M. A. (2021) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557521666210913112030 · Cited by 20
Genome engineering of isogenic human ES cells to model autism disorders
Martinez, R. A., Stein, J. L., Krostag, A.-R., Nelson, A. M., Marken, J., Menon, V., May, R., Yao, Z., Kaykas, A., Geschwind, D. H., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv164 · Cited by 20
Genome Editing Fidelity in the Context of DNA Sequence and Chromatin Structure
Chechik, L. L., Martin, O. A., & Soutoglou, E. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00319 · Cited by 16
A Scaled Framework for CRISPR Editing of Human Pluripotent Stem Cells to Study Psychiatric Disease
Hazelbaker, D. Z., Beccard, A., Bara, A. M., Dabkowski, N., Messana, A., Mazzucato, P., Lam, D., Manning, D. K., Eggan, K. C., & Barrett, L. E. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.09.006 · Cited by 19
Zhou, H., Zhou, M., Li, D., Manthey, J., Lioutikova, E., Wang, H., & Zeng, X. (2017) · BMC Genomics · doi:10.1186/s12864-017-4225-1 · Cited by 18
CRISPR/Cas: An intriguing genomic editing tool with prospects in treating neurodegenerative diseases
Rahman, S., Datta, M., Kim, J., & Jan, A. T. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.014 · Cited by 19
Gene Editing and Gene-Based Therapeutics for Cardiomyopathies
Ohiri, J. C., & McNally, E. M. (2018) · Heart Failure Clinics · doi:10.1016/j.hfc.2017.12.006 · Cited by 17
Zhou, Q., Jiao, L., Li, W., Hu, Z., Li, Y., Zhang, H., Yang, M., Xu, L., & Yan, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910739 · Cited by 17
Epigenetics in the Diagnosis and Therapy of Malignant Melanoma
Santourlidis, S., Schulz, W. A., Araúzo-Bravo, M. J., Daniela Gerovska, D., Ott, P., Bendhack, M. L., Hassan, M., & Erichsen, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031531 · Cited by 20
BoostMEC: predicting CRISPR-Cas9 cleavage efficiency through boosting models
Zarate, O. A., Yang, Y., Wang, X., & Wang, J.-P. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-04998-z · Cited by 17
The impact of nucleosome structure on CRISPR/Cas9 fidelity
Handelmann, C. R., Tsompana, M., Samudrala, R., & Buck, M. J. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad021 · Cited by 17
Utilizing directed evolution to interrogate and optimize CRISPR/Cas guide RNA scaffolds
Bush, K. B., Corsi, G. I., Yan, A. C., Haynes, K., Layzer, J. M., Zhou, J. H., Llanga, T., Gorodkin, J., & Sullenger, B. A. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.06.007 · Cited by 18
Cottingham, H., Judd, L. M., Wisniewski, J. A., Wick, R. R., Stanton, T. D., Vezina, B., Maćešić, N., Peleg, A. Y., Okeke, I. N., Holt, K. E., et al. (2025) · mSystems · doi:10.1128/msystems.01413-24 · Cited by 17
To Crispr And Beyond: The Evolution Of Genome Editing In Stem Cells
Chen, K.-Y. M., & Knoepfler, P. S. (2016) · Regenerative Medicine · doi:10.2217/rme-2016-0107 · Cited by 18
Precise editing of plant genomes – Prospects and challenges
Satheesh, V., Zhang, H., Wang, X., & Lei, M. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.04.010 · Cited by 17
Genetically Engineering the Nervous System with CRISPR-Cas
Sandoval, A., Elahi, H., & Ploski, J. E. (2020) · eNeuro · doi:10.1523/eneuro.0419-19.2020 · Cited by 18
Types I and V Anti-CRISPR Proteins: From Phage Defense to Eukaryotic Synthetic Gene Circuits
Yu, L., & Marchisio, M. A. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.575393 · Cited by 18
Perfecting Targeting in CRISPR
Zhang, H., Li, T., Sun, Y., & Yang, H. (2021) · Annual Review of Genetics · doi:10.1146/annurev-genet-071719-030438 · Cited by 18
Modularization of genetic elements promotes synthetic metabolic engineering
Qi, H., Li, B., Zhang, W., Liu, D., & Yuan, Y. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.04.002 · Cited by 18
Zhang, X., Bhattacharya, A., Pu, C., Dai, Y., Liu, J., Rao, L., & Tian, C. (2024) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2024.05.010 · Cited by 16
Spasskaya, D. S., Davletshin, A. I., Bachurin, S. S., Tutyaeva, V. V., Garbuz, D. G., & Karpov, D. S. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12469-5 · Cited by 16
Liu, Z., Liu, J., Yang, Z., Zhū, L., Zhu, Z., Huang, H., & Jiang, L. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108241 · Cited by 16
Seed sequences mediate off-target activity in the CRISPR-interference system
Rohatgi, N., Fortin, J., Lau, T., Ying, Y., Zhang, Y., Lee, B. L., Costa, M. R., & Reja, R. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100693 · Cited by 19
CRISPR/Cas9 in the Chicken Embryo
Morin, V., Véron, N., & Marcelle, C. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7216-6_7 · Cited by 16
DMSO increases efficiency of genome editing at two non-coding loci
Stratigopoulos, G., Rosa, M. C. D., LeDuc, C. A., Leibel, R. L., & Doege, C. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198637 · Cited by 15
CRISPR-Cas12a Nucleases Bind Flexible DNA Duplexes without RNA/DNA Complementarity
Jiang, W., Singh, J. K., Allen, A., Li, Y., Kathiresan, V., Qureshi, O. A., Tangprasertchai, N. S., Zhang, X., Parameshwaran, H. P., Rajan, R., et al. (2019) · ACS Omega · doi:10.1021/acsomega.9b01469 · Cited by 16
CRISPR/Cas9 Guide RNA Design Rules for Predicting Activity
Hiranniramol, K., Chen, Y., & Wang, X. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0290-4_19 · Cited by 16
Valproic Acid Significantly Improves CRISPR/Cas9-Mediated Gene Editing
Park, H., Shin, J., Choi, H. G., Cho, B., & Kim, J. (2020) · Cells · doi:10.3390/cells9061447 · Cited by 16
CRISPR GENOME SURGERY IN THE RETINA IN LIGHT OF OFF-TARGETING
Cho, G. Y., Schaefer, K. A., Bassuk, A. G., Tsang, S. H., & Mahajan, V. B. (2018) · Retina · doi:10.1097/iae.0000000000002197 · Cited by 15
Sato, G. E., & Kuroda, K. (2023) · Microorganisms · doi:10.3390/microorganisms11041040 · Cited by 16
CRISPR-Cas9 Based Genome Engineering: Opportunities in Agri-Food-Nutrition and Healthcare
Rajendran, S. R. C. K., Yau, Y., Pandey, D., & Kumar, A., V (2015) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2015.0023 · Cited by 17
RNA‐Generated and Gene‐Edited Induced Pluripotent Stem Cells for Disease Modeling and Therapy
Kehler, J., Greco, M., Martino, V., Manickam, P., Yokoe, H., Chen, A. P., Yang, M., Auerbach, J., Jessee, J. A., Götte, M., et al. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25597 · Cited by 15
Smith, S. J., Towers, N., Demetriou, K., & Mohun, T. J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235433 · Cited by 16
Sullivan, N. T., Allen, A. G., Atkins, A., Chung, C.-H., Dampier, W., Nonnemacher, M. R., & Wigdahl, B. L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01872 · Cited by 16
Chabbi, I., Baati, H., Dammak, R., Bahloul, M. M., & Azri, C. (2020) · Human and Ecological Risk Assessment An International Journal · doi:10.1080/10807039.2020.1732189 · Cited by 15
Characterization of Cas9–Guide RNA OrthologsPreprint
Braff, J. L., Yaung, S. J., Esvelt, K. M., & Church, G. M. (2016) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top086793 · Cited by 15
Okada, K., Aoki, K., Tabei, T., Sugio, K., Imai, K., Bonkohara, Y., & Kamachi, Y. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac100 · Cited by 14
Understanding the Molecular Mechanisms of the CRISPR Toolbox Using Single Molecule Approaches
Singh, D., & Ha, T. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.7b00905 · Cited by 14
Fujita, T., Kitaura, F., Yuno, M., Suzuki, Y., Sugano, S., & Fujii, H. (2017) · DNA Research · doi:10.1093/dnares/dsx023 · Cited by 14
Restoration of dystrophin expression and correction of Duchenne muscular dystrophy by genome editing
Aslesh, T., Erkut, E. J. N., & Yokota, T. (2021) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2021.1872539 · Cited by 15
Zhang, J., Du, X., Zhou, X., Jin, D., Miao, J., & Liu, X. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126601 · Cited by 14
Pioneer Factor Improves CRISPR‐Based C‐To‐G and C‐To‐T Base Editing
Yang, C., Dong, X., Ma, Z., Li, B., Bi, C., & Zhang, X. (2022) · Advanced Science · doi:10.1002/advs.202202957 · Cited by 15
CRISPR mediated transactivation in the human disease vector Aedes aegypti
Bui, M., Benetta, E. D., Dong, Y., Zhao, Y., Yang, T., Li, M., Antoshechkin, I. A., Buchman, A. B., Bottino-Rojas, V., James, A. A., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1010842 · Cited by 14
CRISPR-engineered genome editing for the next generation neurological disease modeling
Feng, W., Liu, H., & Kawauchi, D. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.05.019 · Cited by 15
The epigenome editors: How tools such as CRISPR offer new details about epigenetics
Willyard, C. (2017) · Nature Medicine · doi:10.1038/nm0817-900 · Cited by 13
Eukaryotic-driven directed evolution of Cas9 nucleases
(2024) · doi:10.1186/s13059-024-03215-9 · Cited by 15
An Overview and Comparative Analysis of CRISPR-SpCas9 gRNA Activity Prediction Tools
Yuan, H., Song, C., Xu, H., Sun, Y., Anthon, C., Bolund, L., Lin, L., Benabdellah, K., Lee, C. M., Hou, Y., et al. (2025) · The CRISPR Journal · doi:10.1089/crispr.2024.0058 · Cited by 13
Site‐Specific m6A Erasing via Conditionally Stabilized CRISPR‐Cas13b Editor
Xu, Y., Wang, Y., & Liang, F. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202309291 · Cited by 13
Genetic therapies and potential therapeutic applications of CRISPR activators in the eye
Ng, B., Kaukonen, M. K., McClements, M. E., Shamsnajafabadi, H., MacLaren, R. E., & Cehajic‐Kapetanovic, J. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101289 · Cited by 13
CRISPR-Cas12a bends DNA to destabilize base pairs during target interrogation
Soczek, K. M., Cofsky, J. C., Tuck, O. T., Shi, H., & Doudna, J. A. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1192 · Cited by 13
Xu, H., Shi, L., Boob, A. G., Park, W., Tan, S., Tran, V. G., Schultz, J. C., & Zhao, H. (2025) · Metabolic Engineering · doi:10.1016/j.ymben.2025.02.004 · Cited by 13
Modeling cancer processes with CRISPR-Cas9
Lu, X., Qi, X., Zheng, D., & Ji, L.-J. (2015) · Trends in biotechnology · doi:10.1016/j.tibtech.2015.03.007 · Cited by 13
Gene editing in the context of an increasingly complex genome
Blighe, K., DeDionisio, L., Christie, K. A., Chawes, B., Shareef, S., Kakouli‐Duarte, T., Chao-Shern, C., Harding, V., Kelly, R. S., Castellano, L., et al. (2018) · BMC Genomics · doi:10.1186/s12864-018-4963-8 · Cited by 13
Disease modeling and stem cell immunoengineering in regenerative medicine using CRISPR/Cas9 systems
Antao, A. M., Karapurkar, J. K., Lee, D. R., Kim, K.-S., & Ramakrishna, S. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.11.026 · Cited by 14
T cell-specific inactivation of mouse CD2 by CRISPR/Cas9
Beil-Wagner, J., Dössinger, G., Schober, K., Berg, J. V., Tresch, A., Grandl, M., Palle, P., Mair, F., Gerhard, M., Becher, B., et al. (2016) · Scientific Reports · doi:10.1038/srep21377 · Cited by 13
Off-target effects of CRISPRa on interleukin-6 expression
Soubeyrand, S., Lau, P., Peters, V., & McPherson, R. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224113 · Cited by 13
Lamothe, R. C., Storlie, M. D., Espinosa, D. A., Rudlaff, R. M., Browne, P. J., Liu, J., Rivas, A., Devoto, A. E., Oki, J., Khoubyari, A., et al. (2023) · The CRISPR Journal · doi:10.1089/crispr.2022.0089 · Cited by 12
Non-replicative phage particles delivering CRISPR-Cas9 to target major blaCTX-M variants
Nittayasut, N., Yata, T., Chirakul, S., Techakriengkrai, N., & Chanchaithong, P. (2024) · PLoS ONE · doi:10.1371/journal.pone.0303555 · Cited by 15
OliTag-seq enhances in cellulo detection of CRISPR-Cas9 off-targets
Yang, Z.-X., Deng, D.-H., Gao, Z.-Y., Zhang, Z.-K., Fu, Y.-W., Wen, W., Zhang, F., Li, X., Li, H., Zhang, J., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06360-w · Cited by 17
Ohtani, H., Liu, M., Liang, G., Jang, H. J., & Jones, P. A. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae498 · Cited by 13
Fujita, T., & Fujii, H. (2016) · Gene Regulation and Systems Biology · doi:10.4137/grsb.s32520 · Cited by 12
Epigenetic Editing in Prostate Cancer: Challenges and Opportunities
Pacheco, M. B., Camilo, V., Henrique, R., & Jerónimo, C. (2021) · Epigenetics · doi:10.1080/15592294.2021.1939477 · Cited by 12
CasKAS: direct profiling of genome-wide dCas9 and Cas9 specificity using ssDNA mapping
Marinov, G. K., Kim, S. H., Bagdatli, S. T., Higashino, S. I., Trevino, A. E., Tycko, J., Wu, T., Bintu, L., Bassik, M. C., He, C., et al. (2023) · Genome biology · doi:10.1186/s13059-023-02930-z · Cited by 12
DNA-binding of the Tet-transactivator curtails antigen-induced lymphocyte activation in mice
Ottina, E., Peperzak, V., Schoeler, K., Carrington, E. M., Sgonc, R., Pellegrini, M., Preston, S., Herold, M. J., Strasser, A., & Villunger, A. (2017) · Nature Communications · doi:10.1038/s41467-017-01022-4 · Cited by 12
Convolution neural network model for predicting single guide RNA efficiency in CRISPR/Cas9 system
Shrawgi, H., & Sisodia, D. S. (2019) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/j.chemolab.2019.04.008 · Cited by 12
Xu, W., Fu, W., Zhu, P., Li, Z., Wang, C., Wang, C., Zhang, Y., & Zhu, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174125 · Cited by 13
Metadata
- Authors
- Wu, X., Scott, D. A., Kriz, A. J., Chiu, A. C., Hsu, P. D., Dadon, D. B., Cheng, A. W., Trevino, A. E., Konermann, S., Chen, S., Jaenisch, R., Zhang, F., & Sharp, P. A.
- Affiliations
- Koch Institute for Integrative Cancer Research At MIT (US)
- Broad Institute (US)
- Massachusetts Institute of Technology (US)
- Whitehead Institute for Biomedical Research (US)
- Corresponding author
- Zhang, Feng
- Sharp, Phillip A
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2014-04-20
- Volume
- 32
- Issue
- 7
- Pages
- 670-676
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC4145672
- OpenAlex
- W1506494596
- Cited by
- 944
- References
- 47
- Citations by year
- 2026: 26 · 2025: 42 · 2024: 56 · 2023: 61 · 2022: 73 · 2021: 63 · 2020: 75 · 2019: 80 · 2018: 81 · 2017: 97 · 2016: 123 · 2015: 111 · 2014: 54
- FWCI
- 52.65
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- eScholarship (California Digital Library) (submittedVersion)
- PMC
- Funders
- Howard Hughes Medical Institute
- National Institute of Mental Health (DP1MH100706)
- National Cancer Institute (R01CA133404, P01CA042063, P30CA014051, P30-CA-14051, P01 CA 42063)
- National Institute of General Medical Sciences (R01GM034277, R01 GM34277, R37GM034277, T32GM007287)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK097768)
- National Center for Chronic Disease Prevention and Health Promotion (1DP1-MH100706)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R37HD045022)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- Cas9, CRISPR/Cas9, dCas9, genome-wide binding sites, single guide RNA, Streptococcus pyogenes, mouse embryonic stem cells, off-target binding, seed sequence, protospacer adjacent motif, chromatin accessibility, DNA cleavage, target specificity
- MeSH terms
- Animals, Base Sequence, Binding Sites, Cells, Cultured, Deoxyribonuclease I, DNA-Binding Proteins, Models, Genetic, Molecular Sequence Data, Protein Binding, Genome, Mice, Embryonic Stem Cells, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review